National Comprehensive Cancer Network

NCCN Oncology Research Program (ORP)
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN ORP Grant History
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Learn more about clinical trials at this NCCN Member Institution.


Stanford University is an international leader in cancer research and patient care. The mission of the Stanford Clinical Cancer Program is to provide comprehensive care through multidisciplinary collaboration and integrated services, to advance cancer therapies through clinical research, and to train future leaders in the treatment of patients with cancer. The collaborative approach to cancer research and treatment is a hallmark of this program. Surgeons, medical oncologists, radiation oncologists, pediatric oncologists, radiologists, and pathologists participate in sixteen weekly combined modality clinics.

The Clinical Cancer Program at Stanford is comprehensive. Highlights include:

• Translational research and innovative combined modality trials for management of cancers of the prostate, head and neck, breast, lung, colon, liver, melanoma, and other solid tumors.

• Pioneering efforts in the management of Hodgkin's disease and the lymphomas.

• Premier bone marrow transplantation.

• Highly advanced radiation therapy techniques including conformal radiotherapy, intraoperative radiotherapy, high-dose-rate brachytherapy, intravascular brachytherapy, stereotactic radiotherapy, and radio-immunotherapy.

• Specialized therapy for AIDS-related malignancies.

• World-renowned neuro-oncology program providing innovative therapy for brain and spinal cord cancers.

• Risk prevention/genetic screening.

• Leaders in the treatment of pediatric malignancies, particularly lymphomas and sarcomas.

One hundred and sixty faculty members participate in cancer care and clinical research with over 500 active clinical trials. Research on the fundamentals of cancer is conducted in the Center for Molecular and Genetic Medicine and the Center for Clinical Sciences Research.